The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
APOL1 Nephropathy: From Genetics to Clinical Applications
Open accessAbstract
Rates of many types of severe kidney disease are much higher in Black individuals than most other ethnic groups. Much of this disparity can now be attributed to genetic variants in the apoL1 (APOL1) gene found only in individuals with recent African ancestry. These variants greatly increase rates of hypertension-associated ESKD, FSGS, HIV-associated nephropathy, and other forms of nondiabetic kidney disease. We discuss the population genetics of APOL1 risk variants and the clinical spectrum of APOL1 nephropathy. We then consider clinical issues that arise for the practicing nephrologist caring for the patient who may have APOL1 kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Self-citationAPOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Kopp, J. B., Nelson, G. W., Sampath, K., Johnson, R. C., Genovese, G., An, P., Friedman, D., Briggs, W., Dart, R., Korbet, S., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040388 · Cited by 855
Self-citationAPOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Parsa, A., Kao, W. H. L., Xie, D., Astor, B. C., Li, M., Hsu, C.-Y., Feldman, H. I., Parekh, R. S., Kusek, J. W., Greene, T. H., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310345 · Cited by 784
Tzur, S., Rosset, S., Shemer, R., Yudkovsky, G., Selig, S., Tarekegn, A., Bekele, E., Bradman, N., Wasser, W. G., Behar, D. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0861-0 · Cited by 653
Apolipoprotein L-I is the trypanosome lytic factor of human serum
Vanhamme, L., Paturiaux-Hanocq, F., Poelvoorde, P., Nolan, D. P., Lins, L., Van Den Abbeele, J., Pays, A., Tebabi, P., Van Xong, H., Jacquet, A., et al. (2003) · Nature · doi:10.1038/nature01461 · Cited by 500
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
Nichols, B., Jog, P., Lee, J. H., Blackler, D., Wilmot, M., D'Agati, V., Markowitz, G., Kopp, J. B., Alper, S. L., Pollak, M. R., et al. (2015) · Kidney International · doi:10.1038/ki.2014.270 · Cited by 355
Self-citationTransgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice
Beckerman, P., Bi-Karchin, J., Park, A. S. D., Qiu, C., Dummer, P. D., Soomro, I., Boustany-Kari, C. M., Pullen, S. S., Miner, J. H., Hu, C.-A. A., et al. (2017) · Nature Medicine · doi:10.1038/nm.4287 · Cited by 344
The APOL1 Gene and Allograft Survival after Kidney Transplantation
Reeves-Daniel, A. M., DePalma, J. A., Bleyer, A. J., Rocco, M. V., Murea, M., Adams, P. L., Langefeld, C. D., Bowden, D. W., Hicks, P. J., Stratta, R. J., et al. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03513.x · Cited by 330
APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans
Kasembeli, A. N., Duarte, R., Ramsay, M., Mosiane, P., Dickens, C., Dix-Peek, T., Limou, S., Sezgin, E., Nelson, G. W., Fogo, A. B., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050469 · Cited by 326
Collapsing Glomerulopathy in a Patient With COVID-19
Larsen, C. P., Bourne, T. D., Wilson, J. D., Saqqa, O., & Sharshir, M. A. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.04.002 · Cited by 314
End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1
Freedman, B. I., Langefeld, C. D., Andringa, K. K., Croker, J. A., Williams, A. H., Garner, N. E., Birmingham, D. J., Hebert, L. A., Hicks, P. J., Segal, M. S., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38220 · Cited by 299
APOL1 Variants Associate with Increased Risk of CKD among African Americans
Foster, M. C., Coresh, J., Fornage, M., Astor, B. C., Grams, M., Franceschini, N., Boerwinkle, E., Parekh, R. S., & Kao, W. H. L. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010113 · Cited by 267
Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection
Peleg, Y., Kudose, S., D’Agati, V., Siddall, E., Ahmad, S., Nickolas, T., Kisselev, S., Gharavi, A., & Canetta, P. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.04.017 · Cited by 235
Olabisi, O. A., Zhang, J.-Y., VerPlank, L., Zahler, N., DiBartolo, S., Heneghan, J. F., Schlöndorff, J. S., Suh, J. H., Yan, P., Alper, S. L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522913113 · Cited by 231
Self-citationPopulation-Based Risk Assessment of APOL1 on Renal Disease
Friedman, D. J., Kozlitina, J., Genovese, G., Jog, P., & Pollak, M. R. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050519 · Cited by 226
Self-citationEvolution of the primate trypanolytic factor APOL1
Thomson, R., Genovese, G., Canon, C., Kovacsics, D., Higgins, M. K., Carrington, M., Winkler, C. A., Kopp, J., Rotimi, C., Adeyemo, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400699111 · Cited by 225
Self-citationTreatment with IFN-α, -β, or -γ Is Associated with Collapsing Focal Segmental Glomerulosclerosis
Markowitz, G. S., Nasr, S. H., Stokes, M. B., & D'Agati, V. D. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07311009 · Cited by 221
Larsen, C. P., Beggs, M. L., Saeed, M., & Walker, P. D. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121180 · Cited by 207
Human Trypanosoma evansi Infection Linked to a Lack of Apolipoprotein L-I
Vanhollebeke, B., Truc, P., Poelvoorde, P., Pays, A., Joshi, P. P., Katti, R., Jannin, J. G., & Pays, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063265 · Cited by 187
Lee, B. T., Kumar, V, Williams, T. A., Abdi, R., Bernhardy, A., Dyer, C., Conte, S., Genovese, G., Ross, M. D., Friedman, D. J., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04033.x · Cited by 181
Self-citationApolipoprotein L1 Gene Variants in Deceased Organ Donors Are Associated With Renal Allograft Failure
Freedman, B. I., Julian, B. A., Pastan, S. O., Israni, A. K., Schladt, D., Gautreaux, M. D., Hauptfeld, V., Bray, R. A., Gebel, H. M., Kirk, A. D., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13223 · Cited by 174
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors
Freedman, B. I., Pastan, S. O., Israni, A. K., Schladt, D., Julian, B. A., Gautreaux, M. D., Hauptfeld, V., Bray, R. A., Gebel, H. M., Kirk, A. D., et al. (2016) · Transplantation · doi:10.1097/tp.0000000000000969 · Cited by 173
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD
Freedman, B. I., Limou, S., Ma, L., & Kopp, J. B. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.020 · Cited by 162
Smith, E. E., & Malik, H. S. (2009) · Genome Research · doi:10.1101/gr.085647.108 · Cited by 161
APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline
Peralta, C. A., Bibbins-Domingo, K. B., Vittinghoff, E., Lin, F., Fornage, M., Kopp, J. B., & Winkler, C. A. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015020124 · Cited by 155
APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction
Ma, L., Chou, J. W., Snipes, J. A., Bharadwaj, M. S., Craddock, A. L., Cheng, D., Weckerle, A., Petrović, S., Hicks, P. J., Hemal, A. K., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050567 · Cited by 153
APOL1 Genotype and Renal Function of Black Living Donors
Doshi, M. D., Ortigosa‐Goggins, M., Garg, A. X., Li, L., Poggio, E. D., Winkler, C. A., & Kopp, J. B. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017060658 · Cited by 150
APOL1 and Kidney Disease: From Genetics to Biology
Friedman, D. J., & Pollak, M. R. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034345 · Cited by 140
Self-citationGenetics of kidney failure and the evolving story of APOL1
Friedman, D. J., & Pollak, M. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46263 · Cited by 138
Self-citationThomson, R. P., & Finkelstein, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421953112 · Cited by 128
Kopp, J. B., Winkler, C. A., Zhao, X., Radeva, M., Gassman, J., D’Agati, V. D., Nast, C. C., Wei, C., Reiser, J., Guay‐Woodford, L. M., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111242 · Cited by 125
Self-citationIntracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion
Granado, D., Müller, D., Krausel, V., Kruzel-Davila, E., Schuberth, C. E., Eschborn, M., Wedlich‐Söldner, R., Skorecki, K. L., Pavenstädt, H. J., Michgehl, U., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111220 · Cited by 111
Ulasi, I., Tzur, S., Wasser, W. G., Shemer, R., Kruzel-Davila, E., Feigin, E., Ijoma, C. K., Onodugo, O. D., Okoye, J. U., Arodiwe, E. B., et al. (2013) · Nephron Clinical Practice · doi:10.1159/000353223 · Cited by 108
APOL1nephropathy: from gene to mechanisms of kidney injury
Kruzel-Davila, E., Wasser, W. G., Aviram, S., & Skorecki, K. L. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu391 · Cited by 107
Antisense oligonucleotide treatment ameliorates IFN-γ–induced proteinuria in APOL1-transgenic mice
Aghajan, M., Booten, S. L., Althage, M., Hart, C. E., Ericsson, A., Maxvall, I., Ochaba, J., Menschik-Lundin, A., Hartleib, J., Kuntz, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126124 · Cited by 107
The Innate Immune Factor Apolipoprotein L1 Restricts HIV-1 Infection
Taylor, H. E., Khatua, A. K., & Popik, W. (2013) · Journal of Virology · doi:10.1128/jvi.02828-13 · Cited by 101
Plasma Apolipoprotein L1 Levels Do Not Correlate with CKD
Bruggeman, L. A., O’Toole, J. F., Ross, M. D., Madhavan, S. M., Smurzynski, M., Wu, K., Bosch, R. J., Gupta, S. K., Pollak, M. R., Sedor, J. R., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070700 · Cited by 96
Self-citationEffect of Genetic African Ancestry on eGFR and Kidney Disease
Udler, M. S., Nadkarni, G. N., Belbin, G. M., Lotay, V., Wyatt, C. M., Gottesman, O., Böttinger, E. P., Kenny, E. E., & Peter, I. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050474 · Cited by 96
Ng, D. K., Robertson, C. C., Woroniecki, R. P., Limou, S., Gillies, C. E., Reidy, K. J., Winkler, C. A., Hingorani, S. R., Gibson, K. L., Hjorten, R. C., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw061 · Cited by 96
Worldwide Frequencies of Apolipoprotein L1 Renal Risk Variants
Nadkarni, G. N., Gignoux, C., Sorokin, E. P., Daya, M., Rahman, R., Barnes, K., Wassel, C., & Kenny, E. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1800748 · Cited by 92
Apolipoprotein L1 and Kidney Disease in African Americans
Friedman, D. J., & Pollak, M. R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.02.002 · Cited by 91
Self-citationAPOL1 Null Alleles from a Rural Village in India Do Not Correlate with Glomerulosclerosis
Johnstone, D. B., SHEGOKAR, V. R., Nihalani, D., Rathore, Y. S., Mallik, L., Ashish, ZARE, V. R., Ikizler, H. O., POWAR, R. M., & Holzman, L. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051546 · Cited by 89
Shah, S. S., Lannon, H., Dias, L., Zhang, J.-Y., Alper, S. L., Pollak, M. R., & Friedman, D. J. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020114 · Cited by 89
Self-citationMolina-Portela, M. P., Samanovic, M., & Raper, J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071463 · Cited by 88
Langefeld, C. D., Comeau, M. E., Ng, M. C. Y., Guan, M., Dimitrov, L. M., Mudgal, P., Spainhour, M. H., Julian, B. A., Edberg, J. C., Croker, J. A., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.03.017 · Cited by 84
Human innate immunity against African trypanosomes
Pays, É., & Vanhollebeke, B. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.024 · Cited by 80
Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans
Nadkarni, G. N., Galarneau, G., Ellis, S. B., Nadukuru, R., Zhang, J., Scott, S. A., Schurmann, C., Li, R., Rasmussen‐Torvik, L. J., Kho, A., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.040 · Cited by 80
African Ancestry–Specific Alleles and Kidney Disease Risk in Hispanics/Latinos
Kramer, H., Stilp, A. M., Laurie, C. C., Reiner, A. P., Lash, J. P., Daviglus, M. L., Rosas, S. E., Ricardo, A. C., Tayo, B. O., Flessner, M. F., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016030357 · Cited by 78
Samanovic, M., Molina-Portela, M. P., Chessler, A.-D. C., Burleigh, B. A., & Raper, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000276 · Cited by 76
Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort
Kozlitina, J., Zhou, H., Brown, P. N., Rohm, R. J., Pan, Y., Ayanoglu, G., Du, X., Rimmer, E. F., Reilly, D. F., Roddy, T. P., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015101121 · Cited by 74
UBD modifies APOL1 -induced kidney disease risk
Zhang, J.-Y., Wang, M., Tian, L., Genovese, G., Yan, P., Wilson, J. G., Thadhani, R., Mottl, A. K., Appel, G. B., Bick, A. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716113115 · Cited by 71
Self-citationApolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background
Lannon, H., Shah, S. S., Dias, L., Blackler, D., Alper, S. L., Pollak, M. R., & Friedman, D. J. (2019) · Kidney International · doi:10.1016/j.kint.2019.07.010 · Cited by 70
Self-citationEffect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index
Julian, B. A., Gaston, R. S., Brown, W. M., Reeves-Daniel, A. M., Israni, A. K., Schladt, D. P., Pastan, S. O., Mohan, S., Freedman, B. I., & Divers, J. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14113 · Cited by 69 · cited 1×
“Using donor kidney APOL1 genotype can alter the Kidney Donor Risk Index substantially (62).”
BackgroundChang, J., Husain, S. A., Santoriello, D., Stokes, M. B., Miles, C. D., Foster, K. W., Li, Y., Dale, L., Crew, R. J., Cohen, D. J., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.05.008 · Cited by 67
Most ApoL1 Is Secreted by the Liver
Shukha, K., Mueller, J. L., Chung, R. T., Curry, M. P., Friedman, D. J., Pollak, M. R., & Berg, A. H. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040441 · Cited by 59
Self-citationAPOL1 Risk Genotypes Are Associated With Early Kidney Damage in Children in Sub-Saharan Africa
Ekulu, P. M., Nkoy, A. B., Betukumesu, D. K., Aloni, M. N., Makulo, J. R., Sumaili, E. K., Mafuta, E. M., Elmonem, M. A., Arcolino, F. O., Kitetele, F. N., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.04.002 · Cited by 59
Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors
Locke, J. E., Sawinski, D. L., Reed, R. D., Shelton, B. A., MacLennan, P. A., Kumar, V., Mehta, S. G., Mannon, R. B., Gaston, R. S., Julian, B. A., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002174 · Cited by 55
The APOL1 Long-Term Kidney Transplantation Outcomes Network—APOLLO
Freedman, B. I., & Moxey‐Mims, M. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01510218 · Cited by 55
Characterization of circulating APOL1 protein complexes in African Americans
Weckerle, A., Snipes, J. A., Cheng, D., Gebre, A. K., Reisz, J. A., Murea, M., Shelness, G. S., Hawkins, G. A., Furdui, C. M., Freedman, B. I., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m063453 · Cited by 52
Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles
Bruno, J., Pozzi, N., Oliva, J., & Edwards, J. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.813444 · Cited by 51
BH3 domain-independent apolipoprotein L1 toxicity rescued by BCL2 prosurvival proteins
Heneghan, J. F., Vandorpe, D. H., Shmukler, B. E., Giovinazzo, J. A., Raper, J., Friedman, D. J., Pollak, M. R., & Alper, S. L. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00142.2015 · Cited by 45
Self-citationBesse, W., Mansour, S. G., Jatwani, K., Nast, C. C., & Brewster, U. C. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0330-7 · Cited by 45
A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy
Skorecki, K. L., Lee, J. H., Langefeld, C. D., Rosset, S., Tzur, S., Wasser, W. G., Shemer, R., Hawkins, G. A., Divers, J., Parekh, R. S., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw451 · Cited by 44
Self-citationAPOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story
Kruzel-Davila, E., Wasser, W. G., & Skorecki, K. L. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2017.07.002 · Cited by 44
Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry
Reidy, K. J., Hjorten, R. C., & Parekh, R. S. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000603 · Cited by 44
Histopathologic Effect of APOL1 Risk Alleles in PLA2R-Associated Membranous Glomerulopathy
Larsen, C. P., Beggs, M. L., Walker, P. D., Saeed, M., Ambruzs, J. M., & Messias, N. C. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.02.024 · Cited by 41
Activity of trypanosome lytic factor: A novel component of innate immunity
Thomson, R. P., Samanovic, M. I., & Raper, J. (2009) · Future Microbiology · doi:10.2217/fmb.09.57 · Cited by 36
APOL1-Associated Kidney Disease in Brazil
Riella, C. V., Siemens, T. A., Wang, M., Campos, R. P., de Moraes, T. P., Riella, L. V., Friedman, D. J., RIELLA, M. C., & Pollak, M. R. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.03.006 · Cited by 36
Self-citationPractical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation
Mena‐Gutierrez, A., Reeves‐Daniel, A., Jay, C. L., & Freedman, B. I. (2019) · Transplantation · doi:10.1097/tp.0000000000002933 · Cited by 33
Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants
Nadkarni, G. N., Chauhan, K., Verghese, D. A., Parikh, C. R., Do, R., Horowitz, C. R., Böttinger, E. P., & Coca, S. G. (2018) · Kidney International · doi:10.1016/j.kint.2018.01.026 · Cited by 32
An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts
Robertson, C. C., Gillies, C. E., Putler, R. K. B., Ng, D. K., Reidy, K. J., Crawford, B. D., & Sampson, M. G. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw317 · Cited by 26
A Brief History of APOL1 : A Gene Evolving
Friedman, D. J. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2017.07.003 · Cited by 24
Self-citation
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Tuttle, K. R., Agarwal, R., Alpers, C. E., Bakris, G. L., Brosius, F. C., Kolkhof, P., & Uribarri, J. (2022) · Kidney International · doi:10.1016/j.kint.2022.05.012 · Cited by 668
Metadata
- Authors
- Friedman, D. J., & Pollak, M. R.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2020-07-02
- Volume
- 16
- Issue
- 2
- Pages
- 294-303
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W3040054418
- Cited by
- 270
- References
- 72
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.